4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Prime Medicine, Inc. (PRME) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 146 employees. Its market capitalization is roughly $764 million. In the fiscal year ended 2025-12-31, PRME reported $5M in revenue and ($201M) in net income.
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.
Interactive charts & full statements → Open the PRME valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $5M | $3M | $0M | $0M | — |
| Operating Income (EBIT) | ($208M) | ($202M) | ($191M) | ($116M) | — |
| Net Income | ($201M) | ($196M) | ($198M) | ($122M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $1M | $1M | $2M | — |
| Operating Income (EBIT) | ($51M) | ($49M) | ($54M) | ($53M) | ($52M) | — |
| Net Income | ($49M) | ($46M) | ($51M) | ($53M) | ($52M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $343M | $298M | $194M | $360M | — |
| Total Liabilities | $222M | $144M | $61M | $44M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRME viewer.
About TickerBase · Data methodology & sources